首页 | 本学科首页   官方微博 | 高级检索  
     


Comprehensive Genomic Profiling Identifies a Subset of Crizotinib‐Responsive ALK‐Rearranged Non‐Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Authors:Alexa B. Schrock  Justin Allen  Eric Sanford  Kyle Gowen  Atul Kulkarni  Jie He  James H. Suh  Doron Lipson  Julia A. Elvin  Roman Yelensky  Zachary Chalmers  Juliann Chmielecki  Nir Peled  Samuel J. Klempner  Kashif Firozvi  Garrett M. Frampton  Julian R. Molina  Smitha Menon  Julie R. Brahmer  Heber MacMahon  Jan Nowak  Sai‐Hong Ignatius Ou  Marjorie Zauderer  Marc Ladanyi  Maureen Zakowski  Neil Fischbach  Jeffrey S. Ross  Phil J. Stephens  Vincent A. Miller  Heather Wakelee  Shridar Ganesan  Ravi Salgia
Affiliation:1. Foundation Medicine Inc., Cambridge, Massachusetts, USA;2. Cancer Institute of New Jersey, New Brunswick, New Jersey, USA;3. Davidoff Cancer Center, Tiqwa, Israel;4. Chao Family Comprehensive Cancer Center, School of Medicine, University of California, Irvine, Orange, California, USA;5. Maryland Hematology‐Oncology, Wheaton, Maryland, USA;6. Mayo Clinic, Rochester, Minnesota, USA;7. Froedtert Cancer Center, Milwaukee, Wisconsin, USA;8. Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA;9. Department of Radiology, The University of Chicago, Chicago, Illinois, USA;10. Department of Pathology, North Shore University Health System, Evanston, Illinois, USA;11. Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA;12. Bridgeport Oncology, Bridgeport, Connecticut, USA;13. Albany Medical College, Albany, New York, USA;14. Department of Medicine, Division of Oncology, School of Medicine, Stanford University, Stanford, California, USA;15. Department of Medicine, The University of Chicago, Chicago, Illinois, USA
Abstract:
Keywords:ALK  Crizotinib  Fluorescence in situ hybridization  Genomic profiling  Fusion
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号